These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32940891)

  • 1. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
    Zhang H; Dong Y; Ao X; Fu B; Dong L;
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
    Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
    Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is long-term warfarin therapy necessary in Chinese patients with atrial fibrillation after bioprosthetic mitral valve replacement and left atrial appendage obliteration?
    Zhang L; Jiang S; Ren C; Gao C
    Heart Surg Forum; 2015 Feb; 18(1):E11-6. PubMed ID: 25881216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
    Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
    Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
    Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
    Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
    Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
    Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
    Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
    Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement.
    Haymart B; Kong X; Ali M; Schaefer JK; Froehlich JB; Ryan N; Stallings B; Barnes GD; Kaatz S
    Am J Med; 2024 May; 137(5):449-453. PubMed ID: 38280559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements.
    Pasciolla S; Zizza LF; Le T; Wright K
    Clin Drug Investig; 2020 Sep; 40(9):839-845. PubMed ID: 32607688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
    van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
    Colli A; Mestres CA; Castella M; Gherli T
    J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
    Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
    JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
    Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
    Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.